Heinemann, Stephanie

[["dc.bibliographiccitation.journal","Frontiers in Public Health"],["dc.bibliographiccitation.volume","10"],["dc.contributor.affiliation","Schröder, Dominik; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Heesen, Gloria; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Heinemann, Stephanie; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Hummers, Eva; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Jablonka, Alexandra; 2Department of Rheumatology and Immunology, Hannover Medical School, Hanover, Germany"],["dc.contributor.affiliation","Steffens, Sandra; 2Department of Rheumatology and Immunology, Hannover Medical School, Hanover, Germany"],["dc.contributor.affiliation","Mikuteit, Marie; 2Department of Rheumatology and Immunology, Hannover Medical School, Hanover, Germany"],["dc.contributor.affiliation","Niewolik, Jacqueline; 2Department of Rheumatology and Immunology, Hannover Medical School, Hanover, Germany"],["dc.contributor.affiliation","Overbeck, Tobias R.; 4Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany"],["dc.contributor.affiliation","Kallusky, Jonathan; 4Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany"],["dc.contributor.affiliation","Müller, Frank; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.author","Schröder, Dominik"],["dc.contributor.author","Heesen, Gloria"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Jablonka, Alexandra"],["dc.contributor.author","Steffens, Sandra"],["dc.contributor.author","Mikuteit, Marie"],["dc.contributor.author","Niewolik, Jacqueline"],["dc.contributor.author","Kallusky, Jonathan"],["dc.contributor.author","Müller, Frank"],["dc.contributor.author","Overbeck, Tobias R."],["dc.date.accessioned","2022-04-26T12:34:44Z"],["dc.date.available","2022-04-26T12:34:44Z"],["dc.date.issued","2022"],["dc.date.updated","2022-05-10T16:09:22Z"],["dc.description.abstract","Background: Restrictions to contain the COVID-19 pandemic affect the social participation of people worldwide. Especially those at high risk for a severe disease tend to abstain from social gatherings. While there are a few questionnaires to measure social participation in elderly or chronic patients, a valid survey instrument that includes pandemic-related social participation is needed. Methods We developed a social participation questionnaire that aims to assess pandemic-related restrictions in social participation. Items were developed using a theory and literature-based approach and then compiled in a discursive process involving experts and lay people. This was followed by the validation of the questionnaire through a cross-sectional survey on 431 individuals. Items with low item-total correlations and low factor loadings using exploratory factor analysis [EFA] were excluded. Using EFA on the remaining items, the factor structure was retrieved and tested with a confirmatory factor analysis [CFA]. Internal consistency was assessed with Chronbachs α. Results Initially, 27 items were developed which were used for validation. 13 items were excluded due to low item-total correlations and factors loadings. EFA of the remaining 14 items revealed three factors which were identified as domains “active social participation,” “wellbeing,” and “restrictions”. CFA showed an acceptable model fit using the three-dimensional structure. Chronbachs α of 0.81 and McDonalds Ω of 0.87 indicate good internal consistency. Correlation analysis showed an association between the developed questionnaire and previously-established participation and mental health scales. Conclusion This study suggests that our 14 item questionnaire is of high reliability and validity and can be used to measure social participation during a pandemic."],["dc.identifier.doi","10.3389/fpubh.2022.831087"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/106769"],["dc.language.iso","en"],["dc.publisher","Frontiers Media S.A."],["dc.relation","DEFEnse Against COVID-19 STudy"],["dc.relation.issn","2296-2565"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights.uri","http://creativecommons.org/licenses/by/4.0/"],["dc.title","Development and Validation of a Questionnaire to Assess Social Participation of High Risk-Adults in Germany During the COVID-19 Pandemic"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.contributor.author","Demmer, Iris"],["dc.contributor.author","El-Sayed, Iman"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Königs, Gloria"],["dc.contributor.author","Müller, Frank"],["dc.contributor.author","Müllenmeister, Christina"],["dc.contributor.author","Nußbaum, Kathrin"],["dc.contributor.author","Schmachtenberg, Tim"],["dc.contributor.author","Schröder, Dominik"],["dc.contributor.editor","Roder, Sascha"],["dc.contributor.editorcorporation","Sascha Roder"],["dc.date.accessioned","2022-11-07T10:03:36Z"],["dc.date.available","2022-11-07T10:03:36Z"],["dc.date.issued","2022"],["dc.identifier.isbn","978-3-00-073127-3"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/116942"],["dc.language.iso","de"],["dc.publisher","Universitätsmedizin Göttingen"],["dc.publisher.place","Göttingen"],["dc.relation","DEFEnse Against COVID-19 STudy"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.title","(Er-)Leben mit Long COVID"],["dc.title.subtitle","Projektergebnisse einer qualitativen Studie bildhaft interpretiert"],["dc.type","book"],["dc.type.internalPublication","yes"],["dc.type.subtype","collection_book"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1"],["dc.bibliographiccitation.journal","Zeitschrift für Rheumatologie"],["dc.bibliographiccitation.lastpage","11"],["dc.bibliographiccitation.volume","May 6"],["dc.contributor.author","Müller, Frank"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Noack, Eva Maria"],["dc.contributor.author","Heesen, Gloria"],["dc.contributor.author","Dopfer-Jablonka, Alexandra"],["dc.contributor.author","Mikuteit, Marie"],["dc.contributor.author","Niewolik, Jacqueline"],["dc.contributor.author","Steffens, Sandra"],["dc.contributor.author","Schröder, Dominik"],["dc.creator.author","Frank Müller"],["dc.creator.author","Stephanie Heinemann"],["dc.creator.author","Eva Hummers"],["dc.creator.author","Eva Maria Noack"],["dc.creator.author","Gloria Heesen"],["dc.creator.author","Alexandra Dopfer-Jablonka"],["dc.creator.author","Marie Mikuteit"],["dc.creator.author","Jacqueline Niewolik"],["dc.creator.author","Sandra Steffens"],["dc.creator.author","Dominik Schröder"],["dc.date.accessioned","2022-05-07T01:54:33Z"],["dc.date.available","2022-05-07T01:54:33Z"],["dc.date.issued","2022"],["dc.description.abstract","Immunocompromised people are less likely to be vaccinated, despite an increased benefit of many vaccinations in terms of benefit-risk assessment, including the vaccines against SARS CoV-2 (COVID-19). Attitudes, expectations, and experiences with previous vaccinations influence the decision to get vaccinated."],["dc.identifier.doi","10.1007/s00393-022-01213-5"],["dc.identifier.pmid","35523964"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/108140"],["dc.identifier.url","https://publications.goettingen-research-online.de/handle/2/107676"],["dc.language.iso","de"],["dc.relation","DEFEnse Against COVID-19 STudy"],["dc.relation.eissn","1435-1250"],["dc.relation.issn","0340-1855"],["dc.relation.issn","1435-1250"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.subject.gro","Immunosuppression; SARS-CoV‑2; Vaccination; Vaccination acceptance; Vaccine Uptake; Vaccine hesitancy"],["dc.title","Impfeinstellung, Erwartungen und Impferfahrung von Immunsupprimierten bei COVID-19 Impfungen - Ergebnisse einer Längsschnittstudie"],["dc.title.alternative","Immunosuppressed people's beliefs, expectations, and experiences with COVID-19 vaccinations: Results of a longitudinal study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","403"],["dc.bibliographiccitation.firstpage","403"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","BMC Infectious Diseases"],["dc.bibliographiccitation.volume","22"],["dc.contributor.author","Dopfer-Jablonka, Alexandra"],["dc.contributor.author","Steffens, Sandra"],["dc.contributor.author","Müller, Frank"],["dc.contributor.author","Mikuteit, Marie"],["dc.contributor.author","Niewolik, Jacqueline"],["dc.contributor.author","Cossmann, Anne"],["dc.contributor.author","Stankov, Metodi V."],["dc.contributor.author","Behrens, Georg M. N."],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Heesen, Gloria"],["dc.contributor.author","Schröder, Dominik"],["dc.contributor.author","Roder, Sascha"],["dc.contributor.author","Klawonn, Frank"],["dc.contributor.author","Vahldiek, Kai"],["dc.contributor.author","Hasenkamp, Justin"],["dc.contributor.author","Kallusky, Jonathan"],["dc.contributor.author","Falk, Christine S."],["dc.contributor.author","Overbeck, Tobias R."],["dc.contributor.author","Heinemann, Stephanie"],["dc.date.accessioned","2022-04-29T07:33:23Z"],["dc.date.accessioned","2022-08-12T12:57:45Z"],["dc.date.available","2022-04-29T07:33:23Z"],["dc.date.available","2022-08-12T12:57:45Z"],["dc.date.issued","2022-04-25"],["dc.date.updated","2022-07-29T12:00:25Z"],["dc.description.abstract","Background\r\n Immunocompromised people (ICP) and elderly individuals (older than 80 years) are at increased risk for severe coronavirus infections. To protect against serious infection with SARS-CoV-2, ICP are taking precautions that may include a reduction of social contacts and participation in activities which they normally enjoy. Furthermore, for these people, there is an uncertainty regarding the effectiveness of the vaccination. The COVID-19 Contact (CoCo) Immune study strives to characterize the immune response to COVID-19 vaccination in immunocompromised, elderly people, and patients with hematological or oncological diseases. The study uses blood-based screenings to monitor the humoral and cellular immune response in these groups after vaccination. Questionnaires and qualitative interviews are used to describe the level of social participation.\r\n \r\n \r\n Methods\r\n The CoCo Immune Study is a mixed methods prospective, longitudinal, observational study at two large university hospitals in Northern Germany. Starting in March 2021, it monitors anti-SARS-CoV-2 immune responses and collects information on social participation in more than 600 participants, at least 18 years old. Inclusion criteria and subcohorts: Participants with (1) regularly intake of immunosuppressive medication (ICP-cohort) or (2) age ≥ 80 years (80 + -cohort). Additionally, patients with current or former (3) myeloid, (4) lymphatic disease or (5) solid tumor under checkpoint inhibition (3–5: HO-cohort). Exclusion criteria: (1) refusal to give informed consent, (2) contraindication to blood testing, (3) inability to declare consent. Participants complete a questionnaire at four different time points: prior to full vaccination, and 1, 6 and 12 months after completed vaccination. In addition, participants draw blood samples themselves or through a local health care provider and send them with their questionnaires per post at the respective time points after vaccination. Patients of the HO cohort dispense additional blood samples at week 3 to 12 and at month 6 to 9 after 2nd vaccination to gain additional knowledge in B and T cell responses. Selected participants are invited to qualitative interviews about social participation.\r\n \r\n \r\n Discussion\r\n This observational study is designed to gain insight into the immune response of people with weakened immune systems and to find out how social participation is affected after COVID-19 vaccination.\r\n Trial registration: This study was registered with German Clinical Trial Registry (registration number: DRKS00023972) on 30th December 2020."],["dc.description.sponsorship","Open-Access-Publikationsfonds 2022"],["dc.identifier.citation","BMC Infectious Diseases. 2022 Apr 25;22(1):403"],["dc.identifier.doi","10.1186/s12879-022-07347-w"],["dc.identifier.pmid","35468758"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/106987"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/112723"],["dc.language.iso","en"],["dc.relation","DEFEnse Against COVID-19 STudy"],["dc.relation.eissn","1471-2334"],["dc.relation.issn","1471-2334"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.rights.holder","The Author(s)"],["dc.subject","SARS-CoV-2"],["dc.subject","COVID-19"],["dc.subject","Pandemic"],["dc.subject","Humoral and cellular immunity"],["dc.subject","Immunocompromised people"],["dc.subject","Elderly"],["dc.subject","Hematology"],["dc.subject","Solid tumor"],["dc.subject","Checkpoint inhibition"],["dc.subject","Serological testing"],["dc.subject","Coronavirus"],["dc.subject","Social participation"],["dc.subject","Immunogenicity"],["dc.title","SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","97"],["dc.bibliographiccitation.firstpage","97"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","European journal of medical research"],["dc.bibliographiccitation.volume","27"],["dc.contributor.author","Schröder, Dominik"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Heesen, Gloria"],["dc.contributor.author","Klawonn, Frank"],["dc.contributor.author","Mikuteit, Marie"],["dc.contributor.author","Niewolik, Jacqueline"],["dc.contributor.author","Steffens, Sandra"],["dc.contributor.author","Behrens, Georg"],["dc.contributor.author","Jablonka, Alexandra"],["dc.contributor.author","Müller, Frank"],["dc.date.accessioned","2022-06-24T08:23:02Z"],["dc.date.available","2022-06-24T08:23:02Z"],["dc.date.issued","2022-06-22"],["dc.date.updated","2022-07-25T11:19:00Z"],["dc.description.abstract","The influence of immunosuppressive therapy on immunogenicity after COVID-19 vaccination remains unclear. This study surveys patients who receive immunosuppressive therapy about whether or not they paused their immunosuppressive medication while receiving SARS-CoV-2 vaccination."],["dc.description.sponsorship","Open-Access-Publikationsfonds 2022"],["dc.identifier.citation","European Journal of Medical Research. 2022 Jun 22;27(1):97"],["dc.identifier.doi","10.1186/s40001-022-00727-7"],["dc.identifier.pmid","35733228"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/111667"],["dc.language.iso","en"],["dc.relation","DEFEnse Against COVID-19 STudy"],["dc.relation.eissn","2047-783X"],["dc.relation.issn","2047-783X"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.rights.holder","The Author(s)"],["dc.subject","Immunosuppression"],["dc.subject","SARS-CoV-2"],["dc.subject","COVID-19"],["dc.subject","Immunization"],["dc.subject","Immunogenicity"],["dc.subject","Drug compliance"],["dc.subject","Drug adherence"],["dc.title","Who is pausing immunosuppressive medication for COVID-19 vaccination? Results of an exploratory observational trial"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","9924"],["dc.bibliographiccitation.issue","16"],["dc.bibliographiccitation.journal","International Journal of Environmental Research and Public Health"],["dc.bibliographiccitation.volume","19"],["dc.contributor.author","Homann, Stefanie"],["dc.contributor.author","Mikuteit, Marie"],["dc.contributor.author","Niewolik, Jacqueline"],["dc.contributor.author","Behrens, Georg"],["dc.contributor.author","Stölting, Andrea"],["dc.contributor.author","Müllenmeister, Christina"],["dc.contributor.author","El-Sayed, Iman"],["dc.contributor.author","Happle, Christine"],["dc.contributor.author","Steffens, Sandra"],["dc.contributor.author","Jablonka, Alexandra"],["dc.contributor.author","Müller, Frank"],["dc.contributor.author","Schröder, Dominik"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.orcid","0000-0003-3111-621X"],["dc.contributor.orcid","0000-0002-7084-9013"],["dc.contributor.orcid","0000-0002-9496-9423"],["dc.contributor.orcid","0000-0002-3564-4725"],["dc.contributor.orcid","0000-0002-3937-5956"],["dc.contributor.orcid","0000-0002-5500-7416"],["dc.contributor.orcid","0000-0001-7129-100X"],["dc.creator.author","Stefanie Homann"],["dc.creator.author","Marie Mikuteit"],["dc.creator.author","Jacqueline Niewolik"],["dc.creator.author","Georg Behrens"],["dc.creator.author","Andrea Stölting"],["dc.creator.author","Frank Müller"],["dc.creator.author","Dominik Schröder"],["dc.creator.author","Stephanie Heinemann"],["dc.creator.author","Christina Müllenmeister"],["dc.creator.author","Iman El-Sayed"],["dc.creator.author","Christine Happle"],["dc.creator.author","Sandra Steffens"],["dc.creator.author","Alexandra Jablonka"],["dc.date.accessioned","2022-10-13T11:36:39Z"],["dc.date.available","2022-10-13T11:36:39Z"],["dc.date.issued","2022"],["dc.description.abstract","Background: Patients who are post-COVID-19 will require more treatment soon. Therefore, it is important to understand the root cause of their psychological and somatic conditions. Previous studies showed contradictory results on the influence of pre-existing mental conditions. The present study examines the influence of these pre-existing conditions and their pre-treatment on the severity of post-COVID-19 symptoms. Methods: This analysis employs questionnaire data from a large study sample in Germany. Overall, 801 participants were included. All participants rated their health status on a scale from 0 to 100. Fatigue, depression, and anxiety were measured using the FAS, PHQ-9, and GAD-7 scales. Results: All pre-pandemic values showed no significant differences between the groups. The current health status was rated similarly by the recovered patients (μ = 80.5 ± 17.0) and the control group (μ = 81.2 ± 18.0) but significantly worse by acutely infected (μ = 59.0 ± 21.5) and post-COVID-19 patients (μ = 54.2 ± 21.1). Fatigue, depression, and anxiety were similar for recovered patients and the control group. By contrast, there were significant differences between the control and the post-COVID-19 groups concerning fatigue (45.9% vs. 93.1%), depression (19.3% vs. 53.8%), and anxiety (19.3% vs. 22.3%). Conclusion: Fatigue and psychological conditions of post-COVID-19 patients are not associated with pre-existing conditions."],["dc.identifier.doi","10.3390/ijerph19169924"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/116305"],["dc.identifier.url","https://www.mdpi.com/1660-4601/19/16/9924"],["dc.language.iso","en"],["dc.relation","DEFEnse Against COVID-19 STudy"],["dc.relation.issn","1660-4601"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.title","Effects of Pre-Existing Mental Conditions on Fatigue and Psychological Symptoms Post-COVID-19"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","npj Primary Care Respiratory Medicine"],["dc.bibliographiccitation.volume","31"],["dc.contributor.author","Jablonka, Alexandra"],["dc.contributor.author","Dopfer, Christian"],["dc.contributor.author","Happle, Christine"],["dc.contributor.author","Shalabi, Andree"],["dc.contributor.author","Wetzke, Martin"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Friede, Tim"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Hillermann, Nele"],["dc.contributor.author","Simmenroth, Anne"],["dc.contributor.author","Müller, Frank"],["dc.date.accessioned","2021-12-21T12:22:50Z"],["dc.date.available","2021-12-21T12:22:50Z"],["dc.date.issued","2021"],["dc.description.abstract","The presence of acute infectious respiratory diseases (ARD) is one of the main reasons why recently arrived refugees seek medical help. This paper investigates the incidence rates of acute respiratory diseases in an adult refugee population as well as associated sociodemographic factors and drug treatments. We conducted a retrospective observational study of deidentified medical records. The data were collected between 2015 and 2019 in the health care centers of two large German initial reception centers for refugees. Multivariable analyses controlling for sociodemographics were carried out using generalized estimating equations. Out of 10,431 eligible residents, 6965 medical encounters of 2840 adult patients were recorded over 30 months. Of all the adult patients, 34.4% sought medical help for a respiratory symptom or diagnosis at least once. Older patients and patients from Sub-Saharan Africa sought help less often. The occurrence of ARD showed a typical distribution over the course of the year. Facility occupancy was not associated with ARD occurrence. Acute respiratory symptoms are a leading cause for adult refugee patients to seek medical care. The doctor contact rates due to ARD were consistently two to three times higher among refugees than among German residents."],["dc.identifier.doi","10.1038/s41533-021-00261-9"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/97163"],["dc.language.iso","en"],["dc.relation","DICTUM Friedland - Digitale Kommunikationshilfen für nicht-deutschsprechende Patienten im Grenzdurchgangslager Friedland"],["dc.relation.issn","2055-1010"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.title","Acute respiratory infections in an adult refugee population: an observational study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.journal","Frontiers in Public Health"],["dc.bibliographiccitation.volume","10"],["dc.contributor.affiliation","Heesen, Gloria; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Schröder, Dominik; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Müller, Frank; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Hummers, Eva; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Klawonn, Frank; 2Department of Computer Science, Ostfalia University of Applied Sciences, Wolfenbuettel, Germany"],["dc.contributor.affiliation","Mikuteit, Marie; 4Department of Rheumatology and Immunology, Hannover Medical School, Germany"],["dc.contributor.affiliation","Niewolik, Jacqueline; 4Department of Rheumatology and Immunology, Hannover Medical School, Germany"],["dc.contributor.affiliation","Steffens, Sandra; 4Department of Rheumatology and Immunology, Hannover Medical School, Germany"],["dc.contributor.affiliation","Cossmann, Anne; 4Department of Rheumatology and Immunology, Hannover Medical School, Germany"],["dc.contributor.affiliation","Behrens, Georg; 4Department of Rheumatology and Immunology, Hannover Medical School, Germany"],["dc.contributor.affiliation","Dopfer-Jablonka, Alexandra; 4Department of Rheumatology and Immunology, Hannover Medical School, Germany"],["dc.contributor.affiliation","Heinemann, Stephanie; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.author","Heesen, Gloria"],["dc.contributor.author","Schröder, Dominik"],["dc.contributor.author","Müller, Frank"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Klawonn, Frank"],["dc.contributor.author","Mikuteit, Marie"],["dc.contributor.author","Niewolik, Jacqueline"],["dc.contributor.author","Steffens, Sandra"],["dc.contributor.author","Cossmann, Anne"],["dc.contributor.author","Behrens, Georg"],["dc.contributor.author","Dopfer-Jablonka, Alexandra"],["dc.contributor.author","Heinemann, Stephanie"],["dc.date.accessioned","2022-06-13T06:22:30Z"],["dc.date.available","2022-06-13T06:22:30Z"],["dc.date.issued","2022-06-10"],["dc.date.updated","2022-06-24T06:43:46Z"],["dc.description.abstract","Immunocompromised persons are at an increased risk for a severe SARS-CoV-2 infection and their safety behaviors may influence their social participation. Vaccinated persons have a lower incidence of infection and severe disease when infected compared to non-vaccinated persons. Therefore, their behavior may change and their social participation may increase after a complete vaccination. The aim of this study was to explore social participation of immunocompromised persons before and after complete COVID-19 vaccination. Between March and September 2021, 274 immunocompromised participants were recruited. Survey data were collected at baseline and follow-up from 194 participants including the Index for the Assessment of Health Impairments [IMET], Patient Health Questionnaire-4 [PHQ-4], subjective health status and quality of life. At baseline, participants were not yet completely vaccinated. Complete vaccination was achieved prior to the follow-up questionnaire. IMET scores decreased significantly at follow-up, indicating a higher social participation after complete vaccination. PHQ-4, subjective health status and quality of life did not differ between baseline and follow-up. There were no significant differences across sociodemographic factors. Significant PHQ-4 differences were observed regarding the population size of the participants' home community. Social participation of immunocompromised persons in our study increased after COVID-19 vaccination. Therefore, social participation should be explored further, especially with regards to the impact of vaccination on groups with a high health risk."],["dc.identifier.doi","10.3389/fpubh.2022.877623"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/111155"],["dc.language.iso","en"],["dc.relation","DEFEnse Against COVID-19 STudy"],["dc.relation.eissn","2296-2565"],["dc.relation.issn","2296-2565"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights.uri","http://creativecommons.org/licenses/by/4.0/"],["dc.title","The Impact of COVID-19 Vaccination on the Social Participation of Immunocompromised Persons – Results of a Multicenter Observational Study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.journal","Frontiers in Neurology"],["dc.bibliographiccitation.volume","13"],["dc.contributor.author","Degen, Chantal Vanessa"],["dc.contributor.author","Mikuteit, Marie"],["dc.contributor.author","Niewolik, Jacqueline"],["dc.contributor.author","Schröder, Dominik"],["dc.contributor.author","Vahldiek, Kai"],["dc.contributor.author","Mücke, Urs"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Müller, Frank"],["dc.contributor.author","Behrens, Georg Martin Norbert"],["dc.contributor.author","Klawonn, Frank"],["dc.contributor.author","Dopfer-Jablonka, Alexandra"],["dc.contributor.author","Steffens, Sandra"],["dc.date.accessioned","2022-04-25T12:17:38Z"],["dc.date.available","2022-04-25T12:17:38Z"],["dc.date.issued","2022"],["dc.identifier.doi","10.3389/fneur.2022.884002"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/106665"],["dc.relation","DEFEnse Against COVID-19 STudy"],["dc.relation.issn","1664-2295"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.title","Self-reported Tinnitus and Vertigo or Dizziness in a Cohort of Adult Long COVID Patients"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]